Contact Us
  • Choose License Type

Global Softgel Capsule Market, by Product Type (Gelatin Softgel Capsule and Non-gelatin Softgel Capsule), by Source Type (Gelatin Type-A, Gelatin Type-B, Hydroxy Propyl Methyl Cellulose (HPMC), and Others), by Application (Anti-inflammatory Drugs, Antibiotic Drugs, Health Supplements, Cardiovascular Drugs, and Others), by End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 5,853.18 million in 2020 and is expected to exhibit a CAGR of 5.9% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Key companies are focusing on product launches and product approvals to maintain a competitive edge in the softgel capsule market. For instance, in 2018 Aurora Cannabis Inc, announced to receive sales license from Health Canada to sell the cannabis softgel capsules in Canada and the company also planning to commence export of cannabis softgel capsules in international markets.

Global Softgel Capsule Market – Impact of Coronavirus (COVID-19)

  • The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper the raw material supply for research and development of softgel capsule. Moreover, the COVID-19 pandemic has affected the global softgel capsule market in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and by its financial impact on firms and financial markets. Supply chain and manufacturing activities in India, China, and the U.S. are disrupted due to nationwide lockdowns. Whereas, countries such as Saudi Arabia, UAE, Egypt, and others are facing problems due to transportation of drugs from one place to another.
  • Furthermore, key companies in the softgel capsule markets are restarting the production and manufacturing of pharmaceutical products by following the COVID-19 guidelines prescribed by the government regulatory bodies. For instance, in April 2020, Lonza Group AG, a leading chemical manufacturer stated that the each Lonza manufacturing site and operation units are following the COVID-19 guidelines prescribed by the government regulatory bodies to reduce the spread of COVID-19 infections. They also stated that they are slowly driving the business through this pandemic period, and employees working for the company are frequently tested for COVID-19 infection to avoid the spread of COVID-19 infection.

Browse 33 Market Data Tables and 32 Figures spread through 175 Pages and in-depth TOC on “Global Softgel Capsule Market, by Product Type (Gelatin Softgel Capsule and Non-gelatin Softgel Capsule), by Source Type (Gelatin Type -A, Gelatin Type-B, Hydroxy Propyl Methyl Cellulose (HPMC), and Others), by Application (Anti-inflammatory Drugs, Antibiotic Drugs, Health Supplements, Cardiovascular Drugs, and Others), by End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)”

To know the latest trends and insights prevalent in the global softgel capsule market, click the link below:

https://www.coherentmarketinsights.com/market-insight/softgel-capsule-market-4265

The market is expected to witness significant growth during the forecast period, as market players are focusing on inorganic strategies such as agreements and collaborations to strengthen their position in the global softgel capsule market. For instance, in 2018 Sirio Pharma signed Probiotic Strategy Cooperation Agreement (BC30) with the Kerry Group. The collaboration is expected to drive the probiotic gummy texture softgel capsules sector in China.

Key Takeaways of the Global Softgel Capsule Market:

  • The global softgel capsule market is expected to exhibit a CAGR of 5.9% during the forecast period, owing to pharmaceutical companies focusing on product launches to strengthen their market position. For instance, in 2019, Lotus Pharmaceuticals launched Vinorelbine 20, 30, and 80 mg softgel capsule in Europe. Vinorelbine is the generic version of Pierre Fabre Médicament’s Navelbine, which is used by healthcare professionals for the treatment of breast cancer and advanced non-small cell lung cancer.
  • Among product type, gelatin softgel capsule segment is estimated to account for major market share in 2020, owing to better physiochemical properties such as highly suitable for dry and powdered active pharmaceutical ingredients (API)
  • Among source type, Hydroxy Propyl Methyl Cellulose (HPMC) segment is estimated to account for major market share in 2020, owing to better physiochemical properties such as better dissolving rate in gastrointestinal tract than gelatin capsules
  • Among application, health supplement segment is estimated to account for major market share in 2020, owing to growing demand for health supplements globally due to rising health concerns in individuals
  • Key players operating in the global softgel capsule market include Catalent, Inc, Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc, Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, and KD Pharma Group
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner